Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	52.54	61.83	45.82	7.27	8.19	20.3
Short-Term Investments	84.95	78.57	14.4	-	4.93	-
Cash & Short-Term Investments	137.49	140.4	60.21	7.27	13.12	20.3
Cash Growth	152.04%	133.17%	728.67%	-44.62%	-35.38%	21.31%
Other Current Assets	0.25	0.06	0.08	0.07	0.05	0.22
Total Current Assets	137.74	140.46	60.29	7.33	13.17	20.52
Net Property, Plant & Equipment	0.24	0.25	-	0.01	0.06	-
Total Assets	137.98	140.72	60.29	7.35	13.23	20.52
Accounts Payable	2.46	2.74	2.25	1.76	3.13	1.58
Accrued Expenses	-	-	3	-	-	-
Total Current Liabilities	2.46	2.74	5.25	1.76	3.13	1.58
Long-Term Leases	0.13	0.15	-	-	0.01	-
Total Long-Term Liabilities	0.13	0.15	-	-	0.01	-
Total Liabilities	2.59	2.89	5.25	1.76	3.14	1.58
Common Stock	0.01	0.01	0.01	0	0.01	0.01
Additional Paid-in Capital	228.69	227.2	130.79	65.81	61.87	60.22
Accumulated Other Comprehensive Income	0.1	0.13	0.04	-0.01	0.01	-0
Retained Earnings	-93.4	-89.51	-75.79	-60.21	-51.8	-41.29
Shareholders' Equity	135.39	137.83	55.04	5.59	10.09	18.94
Total Liabilities & Equity	137.98	140.72	60.29	7.35	13.23	20.52
Total Debt	0.13	0.15	0	0	0.01	0
Net Cash (Debt)	137.36	140.24	60.21	7.27	13.11	20.3
Net Cash Growth	-2.06%	132.92%	728.67%	-44.58%	-35.43%	21.31%
Net Cash Per Share	17.61	18.92	15.89	2.63	5.16	8.14
Book Value	135.39	137.83	55.04	5.59	10.09	18.94
Book Value Per Share	17.36	18.60	14.52	2.02	3.97	7.59
Tangible Book Value	135.39	137.83	55.04	5.59	10.09	18.94
Tangible Book Value Per Share	17.36	18.60	14.52	2.02	3.97	7.59

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q